Prograf Related Published Studies
Well-designed clinical trials related to Prograf (Tacrolimus)
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. [2008.09.01]
Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus. [2008.08.27]
Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis. [2008.07.16]
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results. [2008.07.15]
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. [2008.07.15]
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. [2008.07]
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. [2008.07]
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. [2008.07]
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. [2008.06]
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. [2008.06]
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. [2008.05.15]
Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus. [2008.04.27]
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients. [2008.04]
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. [2008.04]
Corticosteroid reduction with tacrolimus (CORRETA) TRIAL: a prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus (Prograf) and mycophenolate mofetil (Cellcept) immunosuppression regimen in kidney transplant recipients: interim analysis. [2008.04]
Multicenter, Randomized Study of the Use of Everolimus With Tacrolimus After Renal Transplantation Demonstrates its Effectiveness. [2008.03.27]
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. [2008.03]
Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen. [2008.03]
A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients. [2008.02]
A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. [2008.02]
Bioequivalence studies of tacrolimus capsule under fasting and fed conditions in healthy male and female subjects. [2008]
Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes. [2007.12]
Comparison of cutaneous tolerance and efficacy of calcitriol 3 mug g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. [2007.11]
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. [2007.10]
Randomized trial of tacrolimus monotherapy: tacrolimus in combination, tacrolimus alone compared (the TICTAC trial). [2007.10]
Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus. [2007.08]
Apparent low absorbers of cyclosporine microemulsion have higher requirements for tacrolimus in renal transplantation. [2007.07]
Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. [2007.07]
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. [2007.06.15]
Tacrolimus monotherapy without steroids after liver transplantation - a prospective randomized double-blinded placebo-controlled trial. [2007.06]
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. [2007.06]
Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial. [2007.05]
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data. [2007.05]
Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study. [2007.03]
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. [2007.03]
Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial. [2007.03]
[Fibroblasts from recurrent pterygium and normal Tenon's capsule exposed to tacrolimus (FK-506)] [2007.03]
The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. [2007.02]
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data. [2007.01.29]
Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. [2007.01]
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. [2007.01]
Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. [2007]
Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial. [2006.12.19]
Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. [2006.12]
Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. [2006.12]
Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. [2006.11]
Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis. [2006.11]
Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy. [2006.11]
Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. [2006.11]
Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation. [2006.10]
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. [2006.10]
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. [2006.09.27]
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. [2006.09]
Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial. [2006.09]
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. [2006.08.27]
Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients. [2006.08]
Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients. [2006.08]
Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. [2006.08]
Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant. [2006.07.15]
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. [2006.07]
Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. [2006.07]
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. [2006.07]
The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis. [2006.07]
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. [2006.07]
Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study. [2006.06]
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. [2006.06]
Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression. [2006.04.18]
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. [2006.04.15]
Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. [2006.04]
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. [2006.03.27]
Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. [2006.03]
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. [2006.03]
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. [2006.03]
No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. [2006.01]
A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. [2006]
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. [2006]
Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. [2006]
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. [2005.12.27]
A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C. [2005.12]
Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. [2005.11.15]
Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients. [2005.11]
Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. [2005.11]
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. [2005.10]
Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. [2005.10]
Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. [2005.10]
Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure. [2005.10]
Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. [2005.09]
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trial. [2005.09]
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. [2005.08.27]
A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year. [2005.08.15]
Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. [2005.08]
Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. [2005.08]
A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. [2005.07.15]
Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results. [2005.07.15]
Neoral versus prograf in simultaneous pancreas-kidney transplantation with portal venous drainage: three-year results of a single-center, open-label, prospective, randomized pilot study. [2005.07]
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. [2005.07]
Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. [2005.07]
Reversal of oliguric tacrolimus nephrotoxicity in children. [2005.07]
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. [2005.06]
Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants. [2005.06]
Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation. [2005.05]
|
